Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections. (Q42686004)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705579%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705579%20AND%20SRC:MED&resulttype=core&format=json

invasive fungal infections

21 January 2020

main subject

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705579%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

12

John R Perfect

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705579%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Issam I Raad

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705579%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

John R Graybill

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705579%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Ana Beatriz Bustamante

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705579%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Veronica Gaona-Flores

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705579%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Claude Afif

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705579%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Donald R Graham

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705579%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Richard N Greenberg

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705579%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Susan Hadley

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705579%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Amelia Langston

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705579%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Ricardo Negroni

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705579%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Punnee Pitisuttithum

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705579%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Angela Restrepo

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705579%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Gary Schiller

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705579%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Lisa Pedicone

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705579%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Andrew J Ullmann

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705579%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

language of work or name

English

0 references

publication date

8 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705579%20AND%20SRC:MED&resulttype=core&format=json

Clinical Infectious Diseases

21 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705579%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705579%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705579%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

1726-1734

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705579%20AND%20SRC:MED&resulttype=core&format=json

Aspergillus fumigatus empyema, arthritis, and calcaneal osteomyelitis in a lung transplant patient successfully treated with posaconazole

21 January 2020

cites work

1 reference

In vitro and in vivo activities of SCH 56592 (posaconazole), a new triazole antifungal agent, against Aspergillus and Candida

21 January 2018

1 reference

Mucormycosis (zygomycosis) in a heart-kidney transplant recipient: recovery after posaconazole therapy

21 January 2018

1 reference

Treatment of Scedosporium apiospermum brain abscesses with posaconazole

21 January 2018

1 reference

Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study.

21 January 2018

1 reference

Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole.

21 January 2018

1 reference

Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies

21 January 2018

1 reference

Pharmacokinetics, safety, and tolerability of oral posaconazole administered in single and multiple doses in healthy adults

21 January 2018

1 reference

Effect of posaconazole on cytochrome P450 enzymes: a randomized, open-label, two-way crossover study

21 January 2018

1 reference

Disposition of posaconazole following single-dose oral administration in healthy subjects

21 January 2018

1 reference

Case study: posaconazole treatment of disseminated phaeohyphomycosis due to Exophiala spinifera

21 January 2018

1 reference

Refractory coccidioidomycosis treated with posaconazole

21 January 2018

1 reference

Posaconazole pharmacokinetics, safety, and tolerability in subjects with varying degrees of chronic renal disease

21 January 2018

1 reference

Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole

21 January 2018

1 reference

Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients

21 January 2018

1 reference

Voriconazole inhibition of tacrolimus metabolism.

21 January 2018

1 reference

Mortality and cancer incidence among individuals with Down syndrome

21 January 2018

1 reference

Itraconazole to prevent fungal infections in chronic granulomatous disease

21 January 2018

1 reference

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

21 January 2018

1 reference

Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections

21 January 2018

1 reference

The safety of voriconazole

21 January 2018

1 reference

Caspofungin: the first representative of a new antifungal class.

21 January 2018

1 reference

In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates

21 January 2018

1 reference

In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/504328

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16705579%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference